Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Msh homeobox 2 pseudogene 1 (MSX2P1) is a human pseudogene located at chromosome 17q23.2. It arose via retrotransposition of MSX2 mRNA and shares high sequence identity with MSX2 but lacks introns and protein-coding capacity. The locus contains remnants of a poly(A) tail, and like other pseudogenes, it is not thought to encode functional proteins. In some contexts, non-coding RNAs from MSX2P1 have been implicated in aberrant cellular proliferation, but there is no evidence for its direct involvement in human disease as a classical gene or pharmacological target. Key distinction: MSX2P1 is sometimes confused with MSX2, a homeobox transcription factor important in craniofacial development and several disease states. Only MSX2—not MSX2P1—is a conventional molecular target with protein-coding function. Summary: MSX2P1 should not be considered a drug target, receptor, or functional entity in the conventional sense. Its aliases and history reflect database entries for non-coding or retroposed loci, not for a canonical protein or molecular target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Msh homeobox 2 pseudogene 1 (MSX2P1).